Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
11/1999
11/09/1999US5981524 Substituted 9-alkyladenines
11/09/1999US5981521 Tetrahydroisoquinoline derivatives as LHRH antagonists
11/09/1999US5981483 Compositions comprising modulators of cytokines of the TGF-β superfamily
11/09/1999US5981470 Administering pharmaceutical agent selected from the group consisting of an angiotensin converting enzyme inhibitor, an angiotensin ii-receptor antagonist, a renin inhibitor, and an angiotensin ii-receptor expression inhibitor
11/09/1999US5980865 Administering to the patient of a pharmaceutical composition containing about 0.005 to about 1.0 mg of ultra-low molecular weight heparins
11/04/1999WO1999055893A1 Retroviral vectors including modified envelope escort proteins
11/04/1999WO1999055734A1 A g-protein coupled 7tm receptor (axor-1)
11/04/1999WO1999055733A1 Cloning of a novel 7tm receptor axor-2
11/04/1999WO1999055690A1 Guanidine derivatives
11/04/1999WO1999055347A2 Treatment of papilloma virus infection using a mycobacterium
11/04/1999WO1999055339A1 Adenosine a1 receptor antagonist containing composition and method for restoring diuretic and renal function
11/04/1999CA2330387A1 Treatment of papilloma virus infection using a mycobacterium
11/04/1999CA2325736A1 Guanidine derivatives
11/03/1999EP0953568A1 Benzothiophene pharmaceutical compounds
11/03/1999EP0952827A1 Amino acid compositions and use thereof in immunosuppression
11/03/1999EP0744944B1 Sexual steroid-containing transdermal therapeutic systems
11/03/1999CN1234071A Keratinocyte grouth factor -2(KGF-2 or fibroblast growth factor-12, FGF-12)
11/03/1999CN1234026A Piperazino derivatives as neurokinin antagonists
11/03/1999CN1233952A Nasal administration of desmopressin
11/03/1999CN1233468A Pharmaceutical composition comprising bisphosphonic acid
11/02/1999US5977382 Benzo[b]thiophene compounds, intermediates, processes, compositions, and methods
11/02/1999US5977359 Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present
11/02/1999US5977337 The nucleic acid molecule may be used in the diagnosis of infection.
11/02/1999US5977311 53BP2 complexes
11/02/1999US5977157 Methods for inhibiting endometriosis
11/02/1999US5977155 Cardiovascular, kidneys
11/02/1999US5977150 Amino acid derivatives of diaryl 1,3,4-oxadiazolone
11/02/1999US5977124 β-adrenergic agonists
11/02/1999US5977115 Alpha 1a adrenergic receptor antagonists
11/02/1999US5977098 Benzo[B]thiophene compounds, intermediates, processes, compositions, and methods
11/02/1999US5977084 Self-assembling polynucleotide delivery method
11/02/1999US5976834 cDNA clone HNFJD15 that encodes a novel human 7-transmembrane receptor
11/02/1999US5976814 DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
11/02/1999US5976524 That produces urine and develops a ureter that facilitates externalization of the urine.
10/1999
10/28/1999WO1999054706A2 Method of treating interstitial cystitis with recombinant hb-egf
10/28/1999WO1999054469A1 B-cell growth factor related protein
10/28/1999WO1999054460A2 Human nucleic acid sequences of normal bladder tissue
10/28/1999WO1999054447A2 Human nucleic acid sequences of bladder tumour tissue
10/28/1999WO1999054351A1 Edg family gene, human h218
10/28/1999WO1999054333A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
10/28/1999WO1999054331A1 Novel asymmetrically substituted xanthine derivatives, method for producing them and their use as medicaments with an adenosine-antagonistic effect
10/28/1999WO1999054320A1 Novel heterocyclically substituted amides with cysteine protease-inhibiting effect
10/28/1999WO1999054310A2 New substituted amides, their production and their use
10/28/1999WO1999054304A1 Heterocyclically substituted amides, their production and their use
10/28/1999WO1999054294A1 New substituted amides, their production and their use
10/28/1999WO1999054293A1 Substituted benzamides, their production and their use as cysteine protease inhibitors
10/28/1999WO1999054284A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
10/28/1999WO1999004773A9 Method for inhibiting bone resorption
10/28/1999DE19818620A1 New polypeptides and their nucleic acids, useful for treatment of bladder tumor and identification of therapeutic agents
10/28/1999DE19818619A1 New nucleic acid sequences expressed in bladder tumor tissue, and derived polypeptides, for treatment of bladder tumor and identification of therapeutic agents
10/28/1999CA2328774A1 Method of treating interstitial cystitis with recombinant heparin-binding epidermal growth factor-like growth factor (hb-egf)
10/28/1999CA2328720A1 Novel heterocyclically substituted amides with cysteine protease-inhibiting effect
10/28/1999CA2328435A1 New substituted amides, their production and their use
10/28/1999CA2328430A1 Substituted benzamides, their production and their use as cysteine protease inhibitors
10/28/1999CA2328413A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
10/28/1999CA2328264A1 Novel asymmetrically substituted xanthine derivatives, method for producing them and their use as medicaments with an adenosine-antagonistic effect
10/28/1999CA2325848A1 B-cell growth factor related protein
10/27/1999EP0951903A1 Therapeutic treatment for renal dysfunction
10/27/1999EP0951556A2 Disease associated protein tyrosine phosphatases
10/27/1999EP0951286A2 Method of treating prostatic diseases using delayed and/or sustained release vitamin d formulations
10/27/1999EP0951285A1 Inhibitors of farnesyl-protein transferase
10/27/1999CN1233181A Method of treating ciliary dyskinesia with uridine triphosphates and related compounds
10/27/1999CN1233173A Therapeutic methods and compositions involving isoflavones
10/26/1999US5972940 Arginine analogues having nitric oxide synthase inhibitor activity
10/26/1999US5972921 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men
10/26/1999US5972917 Treatment and prophylaxis of hyperparathyroidism and hyperproliferative diseases, and in the modulation of the immune and inflammatory responses as well as the treatment of bone depletive disorders
10/26/1999US5972688 HTm4 methods of treatment and assays, agonists and antagonists
10/26/1999US5972606 A polypeptide; treating osteoporosis, eating disorders, brain disorders, adult respiratory disease syndrome, huntington'sdisease, ulcers, cardiovascular disorders, parkinson's disease;
10/26/1999CA2183320C Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
10/21/1999WO1999053036A2 Ste20-related protein kinases
10/21/1999WO1999052907A1 Azabicyclic 5ht1 receptor ligands
10/21/1999WO1999052890A1 Chromanone and thiochromanone derivatives
10/21/1999WO1999052536A1 Use of at least a plant extract of the compositae family, such as the genus bellis
10/21/1999WO1999052514A2 Pharmaceutical composition and combination preparation for immunosuppressive therapy
10/21/1999WO1999033454A3 S-procyclidine for treating urinary incontinence
10/21/1999DE19818614A1 New benzamide derivatives useful as cysteine protease inhibitors for treating neurodegenerative diseases, neuronal damage, stroke, cranial trauma, Alzheimer's disease, etc.
10/21/1999DE19817461A1 New benzamide derivatives useful as cysteine protease inhibitors for treating neurodegenerative diseases, neuronal damage, stroke, cranial trauma, Alzheimer's disease, etc.
10/21/1999DE19817459A1 New heterocyclic amide derivatives useful as cysteine protease inhibitors for treating neurodegenerative diseases, neuronal damage, stroke, cranial trauma, Alzheimer's disease, etc.
10/21/1999DE19816857A1 Novel adenosine antagonists useful in treatment of e.g. neurodegenerative, pulmonary, renal and cardiovascular disorders
10/21/1999CA2369172A1 Ste20-related protein kinases
10/21/1999CA2327782A1 Azabicyclic 5ht1 receptor ligands
10/21/1999CA2327431A1 Pharmaceutical composition
10/20/1999EP0950100A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12)
10/20/1999EP0950046A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
10/20/1999EP0767660B1 Methods and formulations for modulating the human sexual response
10/20/1999EP0767659B1 Transdermal administration of oxybutynin
10/20/1999CN1232469A RET ligand (RetL) for stimulating neural and renal growth
10/20/1999CN1232394A Solid oral dosage forms of valsartan
10/20/1999CN1045777C Tetracyclic derivs. process of preparation and use
10/20/1999CN1045769C Process for preparing sulfurous derivs. of imidazole
10/20/1999CN1045768C Angiotension II antagonists compounds, preparing method and use thereof
10/19/1999US5969151 Pyrazole compounds
10/19/1999US5969134 Cardiovascular disorders, vasoconstriction, hypotensive agents and release of endothelins
10/19/1999US5969120 Dna molecule with synthetically mutated retinoblastoma gene encoding a mutated protein; therapy for a tumor cell with mutation in cyclin gene; antitumor agents
10/19/1999US5968985 Benzoylguanidine derivatives as medicaments
10/19/1999US5968971 Endothelin receptor antagonists
10/19/1999US5968966 Non-oral administering of composition containing l-carnosine
10/19/1999US5968923 (Azetidin-1-ylalkyl) lactams as tachykinin antagonists
10/19/1999US5968819 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
10/19/1999US5968499 Polymeric compounds
1 ... 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 ... 562